ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 116 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $133,000 | +16.7% | 13,933 | -1.3% | 0.09% | +13.6% |
| Q2 2022 | $114,000 | -51.1% | 14,123 | +2.4% | 0.08% | -45.3% |
| Q1 2022 | $233,000 | -39.8% | 13,790 | -23.4% | 0.15% | -37.6% |
| Q4 2021 | $387,000 | -36.1% | 17,992 | +119.3% | 0.24% | -40.5% |
| Q3 2021 | $606,000 | +26.2% | 8,206 | -6.5% | 0.40% | +34.9% |
| Q2 2021 | $480,000 | -27.3% | 8,778 | -1.9% | 0.30% | -30.9% |
| Q1 2021 | $660,000 | -21.9% | 8,945 | -8.8% | 0.43% | -26.1% |
| Q4 2020 | $845,000 | +244.9% | 9,803 | +50.7% | 0.58% | +191.9% |
| Q3 2020 | $245,000 | – | 6,503 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $530,392,000 | 62.60% |
| Logos Global Management LP | 3,156,981 | $172,624,000 | 14.51% |
| Vivo Capital, LLC | 4,220,048 | $230,752,000 | 9.99% |
| Foresite Capital Management V, LLC | 231,200 | $12,642,000 | 4.97% |
| Cormorant Asset Management, LP | 889,454 | $48,635,000 | 1.65% |
| Board of Trustees of The Leland Stanford Junior University | 259,982 | $14,216,000 | 1.33% |
| Redmile Group, LLC | 914,035 | $49,979,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 192,728 | $10,538,000 | 0.71% |
| Financial Advisory Group | 54,041 | $2,955,000 | 0.71% |
| Nan Fung Group Holdings Ltd | 34,950 | $1,911,000 | 0.59% |